Exploring the antioxidant properties of semaglutide: A comprehensive review

dc.contributor.authorYaribeygi, Habib
dc.contributor.authorMaleki, Mina
dc.contributor.authorForouzanmehr, Behina
dc.contributor.authorKesharwani, Prashant
dc.contributor.authorJamialahmadi, Tannaz
dc.contributor.authorKarav, Sercan
dc.contributor.authorSahebkar, Amirhossein
dc.date.accessioned2025-01-27T20:49:41Z
dc.date.available2025-01-27T20:49:41Z
dc.date.issued2024
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractPatients with diabetes commonly experience an aberrant production of free radicals and weakened antioxidative defenses, making them highly susceptible to oxidative stress development. This, in turn, can induce and promote diabetic complications. Therefore, utilizing antidiabetic agents with antioxidative properties can offer dual benefits by addressing hyperglycemia and reducing oxidative damage. Semaglutide, a recently approved oral form of glucagon-like peptide-1 (GLP-1) analogues, has shown potent antidiabetic effects. Additionally, recent studies have suggested that it possesses antioxidative properties. However, the exact effects and the molecular pathways involved are not well understood. In this review, we present the latest findings on the antioxidative impacts of semaglutide and draw conclusions about the mechanisms involved.
dc.identifier.doi10.1016/j.jdiacomp.2024.108906
dc.identifier.issn1056-8727
dc.identifier.issn1873-460X
dc.identifier.issue12
dc.identifier.pmid39549371
dc.identifier.scopus2-s2.0-85209154825
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1016/j.jdiacomp.2024.108906
dc.identifier.urihttps://hdl.handle.net/20.500.12428/25280
dc.identifier.volume38
dc.identifier.wosWOS:001359879000001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofJournal of Diabetes and Its Complications
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectGLP-1 agonist
dc.subjectSemaglutide
dc.subjectDiabetes mellitus
dc.subjectOxidative stress
dc.subjectNRF2
dc.titleExploring the antioxidant properties of semaglutide: A comprehensive review
dc.typeReview Article

Dosyalar